The Taipei District Court yesterday rejected Far Eastern Air Transport’s (FAT, 遠東航空) application for corporate restructuring, bringing the heavily indebted airline a step closer to bankruptcy.
The airline filed for reorganization with the Taipei District Court in February, which temporarily exempted it from paying its debts.
However, the court rejected the application yesterday, saying FAT had not disclosed its actual losses in the application and failed to give the court a clear picture of its financial situation.
The court added that the company did not come up with a sound financial restructuring plan detailing how it planned to reduce its operational costs and pay its debts.
FAT could still appeal the case to the Taiwan High Court, the district court said.
After the district court’s rejection of FAT’s application, creditors could take action to protect their own interests by liquidating FAT’s collateral.
FAT’s financial statement as of Sept. 30 showed that it had liabilities of NT$9.99 billion (US$324.8 million), including NT$4.7 billion in bank loans. The company earlier said losses totaled NT$3.4 billion as of Sept. 30.
Meanwhile, FAT workers’ union staged a protest yesterday against the airlines’ failure to pay overdue salaries and called on the government to intervene to help resolve FAT’s financial difficulties.
Mrs Lin, who has worked for five years at FAT, said the company owed each of its 1,200 employees 1.9 months in salary.
This has made life doubly difficult for her and her three children, she said.
“With nearly two-month in unpaid salary, I have lost the strength to continue working,” Lin said.
“I wish the government would reach out and help FAT, or at least let us know whether the company will be able to survive in the near term,” she said.
A pilot, who wished to remain anonymous, resigned yesterday after finding a job with another firm.
“I think it would be hard for the company to get back on its feet. I therefore chose to leave as I have my own career plan,” he said.
The FAT workers’ union also urged the China Aviation Development Foundation (航發會) to directly invest in FAT, or have China Airlines Ltd (CAL, 華航) take an indirect stake in the airline, the union said in a statement.
Civil Aeronautics Administration (CAA) director-general Billy Chang (張國政) said yesterday that the CAA had sent FAT an official notification on Friday asking the airline to improve its operational shortcomings.
“The CAA is entitled to withdraw the company’s freedom of air if it fails to improve,” he said, adding that the deadline is on Monday.
The company still has an opportunity to explain itself, he said.
CAA said that the airline’s shortcomings include its illegal appointment of a general manager, unpaid salaries, disputes surrounding its aircraft leases and insufficient operational funds.
The CAA will fine FAT NT$3 million and former FAT chairman Bai Shu-ping (白旭屏) NT$1 million.
Chang added that the company still owed the CAA approximately NT$160 million.
Chang said the company had refused to turn in its financial statement, which had made it difficult for interested investors to evaluate its potential for purchase.
“Minister [Minister of Transportation and Communications] Mao [Chi-kuo (毛治國)] told us to prepare for the worst scenario,” Chang said.
NOTABLE SHIFT: By 2030, 50% of all laptops would be assembled in Southeast Asia, while Taiwan would still mostly focus on research and development, a report said Global laptop and desktop computer supply chains are expected to shift significantly away from China in the next 10 years, a Market Intelligence & Consulting Institute (MIC, 產業情報研究所) report said. By 2030, only 40 percent of global laptop production would remain in China, said the report, which was released on Thursday. “The reshuffling of the global supply chain will be one of the most important trends in the next 10 years,” the institute said in the report. “In the long run, key component makers will follow laptop assemblers in moving out of China.” The Taipei-based institute predicted most key component makers
Yageo Corp (國巨), the world’s third-largest supplier of multilayer ceramic capacitors, has formed a strategic alliance with Hon Hai Precision Industry Co (鴻海精密) to develop key electronic components for electric vehicles and digital healthcare, it said yesterday. The alliance is to help Yageo boost its revenue from high-end components for vehicles and industrial, medical and aerospace devices, as well as those used in 5G and Internet-of-Things devices, the company said. The companies signed the strategic alliance agreement at Yageo’s headquarters in New Taipei City’s Sindian District (新店). Their cooperation is to start this quarter, the companies said in a joint statement. “Through the cooperation
SUPPLY CONSTRAINTS: The transferred orders might not provide an immediate revenue boost given local chipmakers’ high utilization rates, a senior analyst said Shares of local contract chipmakers yesterday rose as much as the 10 percent daily limit, as investors bet on orders being transferred from Semiconductor Manufacturing International Corp (SMIC, 中芯國際) after the US imposed export restrictions on the Chinese chipmaker. United Microelectronics Corp (UMC, 聯電) shares soared 10 percent to close at NT$27.5 as 380 million shares changed hands on the Taiwan Stock Exchange. UMC is the world’s No. 3 foundry by revenue, followed by SMIC, according to data from market researcher TrendForce Corp (集邦科技). UMC has product and customer portfolios similar to those of SMIC, TrendForce said, adding that UMC offers 14-nanometer and
‘IMPORTANT MILESTONE’: The firm expects to launch the generic of Revlimid in the US after March 2022. It has already launched the product in some European countries Lotus Pharmaceutical Co Ltd (美時化學製藥) has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for lenalidomide, the company said in a statement on Friday. The ANDA approval is for 2.5mg, 5mg, 10mg, 20mg and 25mg capsules of lenalidomide, which is a generic version of blood cancer drug Revlimid developed by Celgene Corp. It is the first product fully developed and manufactured in Lotus’ facilities in Taiwan. Lotus expects to launch the product in the US — based on its patent litigation settlement with Celgene last year — some time after March